Literature DB >> 16114062

Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.

Celeste L Kremer1, Monika Schmelz, Anne E Cress.   

Abstract

The progressive loss of laminin 5 and the alpha6beta4 integrin is a characteristic of the transition of prostatic intraepithelial neoplasia (PIN) to invasive human prostate cancer. Our objective was to determine if the loss of the interaction with laminin 5 would influence the ability of human epithelial cells to respond to DNA damage. Three cellular damage responses to ionizing radiation (IR) were analyzed including G2 progression, cdc2 phosphorylation, and cell survival. The adhesion of normal human prostate epithelial cells to laminin 5 amplified the G2 arrest induced by IR, and depends on a known cell binding domain of laminin 5. The alteration of G2 arrest was confirmed by an inhibition of phospho-cdc2 nuclear translocation. In contrast, a prostate epithelial cancer cell line blocked in G2 independent of adhesion to laminin 5. The survival of these cell lines in response to IR was unaffected by adhesion to laminin 5. These results suggest that cell adhesion to laminin 5 in normal cells will amplify the IR induced G2 cell cycle progression block without altering cell survival. The loss of laminin 5 and the alpha6beta4 integrin in PIN lesions may contribute to the selection and progression of genetically unstable cell types via attenuation of a DNA damage induced G2 arrest. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16114062      PMCID: PMC2732347          DOI: 10.1002/pros.20316

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  58 in total

Review 1.  The G2-phase DNA-damage checkpoint.

Authors:  M J O'Connell; N C Walworth; A M Carr
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

2.  Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways.

Authors:  P A Klekotka; S A Santoro; H Wang; M M Zutter
Journal:  J Biol Chem       Date:  2001-06-20       Impact factor: 5.157

Review 3.  Checking out the G(2)/M transition.

Authors:  V A Smits; R H Medema
Journal:  Biochim Biophys Acta       Date:  2001-05-28

Review 4.  Towards a mechanistic understanding of tumor invasion--lessons from the alpha6beta 4 integrin.

Authors:  A M Mercurio; I Rabinovitz
Journal:  Semin Cancer Biol       Date:  2001-04       Impact factor: 15.707

5.  Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression.

Authors:  D L Hudson; A T Guy; P Fry; M J O'Hare; F M Watt; J R Masters
Journal:  J Histochem Cytochem       Date:  2001-02       Impact factor: 2.479

6.  Investigation into the mechanism of the loss of laminin 5 (alpha3beta3gamma2) expression in prostate cancer.

Authors:  J Hao; L Jackson; R Calaluce; K McDaniel; B L Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 7.  Regulation of the G2/M transition by p53.

Authors:  W R Taylor; G R Stark
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

8.  Age-related radical-induced DNA damage is linked to prostate cancer.

Authors:  D C Malins; P M Johnson; T M Wheeler; E A Barker; N L Polissar; M A Vinson
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

9.  Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle.

Authors:  A Mettouchi; S Klein; W Guo; M Lopez-Lago; E Lemichez; J K Westwick; F G Giancotti
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

10.  Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma.

Authors:  T L Davis; A E Cress; B L Dalkin; R B Nagle
Journal:  Prostate       Date:  2001-02-15       Impact factor: 4.104

View more
  10 in total

1.  Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress.

Authors:  Che-Jen Hsiao; Yunn-Fang Ho; John T-A Hsu; Wei-Ling Chang; Yi-Cheng Chen; Ya-Ching Shen; Ping-Chiang Lyu; Jih-Hwa Guh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

Review 2.  The Cohesive Metastasis Phenotype in Human Prostate Cancer.

Authors:  William L Harryman; James P Hinton; Cynthia P Rubenstein; Parminder Singh; Raymond B Nagle; Sarah J Parker; Beatrice S Knudsen; Anne E Cress
Journal:  Biochim Biophys Acta       Date:  2016-09-24

Review 3.  The tumor microenvironment is a dominant force in multidrug resistance.

Authors:  Ana Luísa Correia; Mina J Bissell
Journal:  Drug Resist Updat       Date:  2012-02-13       Impact factor: 18.500

4.  Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.

Authors:  Tao Wang; Michael R Alavian; Hira Lal Goel; Lucia R Languino; Thomas J Fitzgerald
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

5.  alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation.

Authors:  Sangita C Pawar; Shona Dougherty; Michael E Pennington; Manolis C Demetriou; B Dino Stea; Robert T Dorr; Anne E Cress
Journal:  Int J Radiat Biol       Date:  2007 Nov-Dec       Impact factor: 2.694

6.  Focal adhesion-chromatin linkage controls tumor cell resistance to radio- and chemotherapy.

Authors:  Katja Storch; Nils Cordes
Journal:  Chemother Res Pract       Date:  2012-06-18

7.  Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.

Authors:  Raymond B Nagle; Anne E Cress
Journal:  Prostate Cancer       Date:  2011-06-21

8.  Mesenchymal stem cells are resistant to carbon ion radiotherapy.

Authors:  Nils H Nicolay; Yingying Liang; Ramon Lopez Perez; Tilman Bostel; Thuy Trinh; Sonevisay Sisombath; Klaus-Josef Weber; Anthony D Ho; Jürgen Debus; Rainer Saffrich; Peter E Huber
Journal:  Oncotarget       Date:  2015-02-10

Review 9.  Cohesive cancer invasion of the biophysical barrier of smooth muscle.

Authors:  William L Harryman; Kendra D Marr; Daniel Hernandez-Cortes; Raymond B Nagle; Joe G N Garcia; Anne E Cress
Journal:  Cancer Metastasis Rev       Date:  2021-01-04       Impact factor: 9.264

Review 10.  Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Authors:  Laure Malric; Sylvie Monferran; Julia Gilhodes; Sabrina Boyrie; Perrine Dahan; Nicolas Skuli; Julie Sesen; Thomas Filleron; Aline Kowalski-Chauvel; Elizabeth Cohen-Jonathan Moyal; Christine Toulas; Anthony Lemarié
Journal:  Oncotarget       Date:  2017-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.